← Back to Clinical Trials
Recruiting NCT06311110

NCT06311110 Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06311110
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Developmental Coordination Disorder
Study Type OBSERVATIONAL
Enrollment 84 participants
Start Date 2023-03-14
Primary Completion 2025-06-01

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 8 Years
Study Type OBSERVATIONAL
Interventions
Vancouver symptom score for dysfunctional elimination symptoms QuestionnaireDevelopmental Coordination Disorder QuestionnaireQuestionnaire concerning impaired toilettraining and comorbities

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 84 participants in total. It began in 2023-03-14 with a primary completion date of 2025-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).

Eligibility Criteria

Inclusion Criteria: * Diagnosed with DCD by a multidisciplinary team (DCD case group) * Children with a typical development, grade and gender matched with the DCD case group (TDC control group). Exclusion Criteria: * A DCD-Q score indicative for DCD (TDC control group) * Presence of other developmental disorders, such as ASS, ADHD or intellectual disability (TDC control group)

Contact & Investigator

Central Contact

Bieke Samijn, PhD

✉ bieke.samijn@ugent.be

📞 +32 9 332 19 38

Principal Investigator

Ellen Vandamme, MD

PRINCIPAL INVESTIGATOR

University Hospital, Ghent

Frequently Asked Questions

Who can join the NCT06311110 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 8 Years, studying Developmental Coordination Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06311110 currently recruiting?

Yes, NCT06311110 is actively recruiting participants. Contact the research team at bieke.samijn@ugent.be for enrollment information.

Where is the NCT06311110 trial being conducted?

This trial is being conducted at Ghent, Belgium, Ghent, Belgium.

Who is sponsoring the NCT06311110 clinical trial?

NCT06311110 is sponsored by University Hospital, Ghent. The principal investigator is Ellen Vandamme, MD at University Hospital, Ghent. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology